http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-81039-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5305109c4efec4cbcdd8bc05bdb00399
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
filingDate 2004-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9823889dd90f9c9a56c2e9403b99c16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c93253feb793680b8124284c539bfb2b
publicationDate 2007-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-81039-C2
titleOfInvention Method of preparation of n-(1-oxopentyl)- n-[[ 2-(1tetrazol-5-yl)[1,1 -biphenyl]-4-yl]methyl] -l-valine (valsartan)
abstract From the starting 4-bromomethyl-2'-(l-triphenylmethyltetrazol-5-yl)biphenyl, N-((2'(1-triphenyl-methyl-tetrazol-5-yl)biphenyl-4-yl)methyl]-(L)-valine benzyl ester of formula 7 is obtained via a reaction with L-valine benzyl ester, and is converted to valsartan of formula I via a reaction with valeryl chloride and removing of protective groups. The method consists in converting, with hydrochloric acid, N-[(2'-(l-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl)methyl]-(L)-valine benzyl ester of formula 7, obtained in the first stage, to N-[(2'-(l-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl)methyl]-(L)-valine benzyl ester hydrochloride of formula III, which is optionally re-crystallized. , (I)
priorityDate 2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415151302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412333127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452415796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10053461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6950584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420347443
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11320097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11285398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636

Total number of triples: 34.